Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
Clinical trial NCT07637162 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07637162
- Sponsor
- Axsome Therapeutics, Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-29
- Primary completion
- 2028-05-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.